Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.41, Iss.5, 2002-01, pp. : 343-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function

By Tesfamariam Belay

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 115-120

Adis International

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors in the Prevention of Stroke

By van Mil A.H.M.

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Comparative Tolerability of the HMG-CoA Reductase Inhibitors

By Farmer J.A. Torre-Amione G.

Drug Safety, Vol. 23, Iss. 3, 2000-09 ,pp. : 197-213

Adis International

Access to resources Recommend Favorite

Inhibitors of HMG-CoA Reductase: Current and Future Prospects

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 11, 2009-01 ,pp. : 1272-1283

Bentham Science Publishers

Access to resources Recommend Favorite

Prevalence of Potentially Severe Drug-Drug Interactions in Ambulatory Patients with Dyslipidaemia Receiving HMG-CoA Reductase Inhibitor Therapy

By Bravo Alexandra E. Rätz

Drug Safety, Vol. 28, Iss. 3, 2005-01 ,pp. : 263-275

Adis International

Access to resources Recommend Favorite